IDH1 and central nervous system cancer: While IDH mutations are not present in glioblastoma, they remain relevant in the context of oxidative stress in IDH-mutant gliomas, as the mutant IDH enzyme produces 2-hydroxyglutarate, which affects cellular redox homeostasis [17].